Table 7 Immune-histochemical results and statistical analyses of AR considered as dichotomized variable as for both cases and controls datasets
IHC parameter | Cut-off | Case dataset (primary ovarian lesions) (%) | Control dataset (primary ovarian lesions) (%) | pValue (Cases vs controls: IHC comparison) | OR (Cases vs controls) (CI 95%) | Â |
|---|---|---|---|---|---|---|
AR | <  1% | 7/39 (17.9) | 2/40 (5) | 0.087 |  |  |
≥ 1% | 32/39 (82.1) | 38/40 (95) |  |  | ||
<  10% | 26/39 (66.7) | 7/40 (17.5) | < 0.001 | 9.429 (3.290–27.020) |  | |
≥ 10% | 13/39 (33.3) | 33/40 (82.5) | ||||
IRS ≤ 2 | 31/39 (79.5) | 13/40 (32.5) | < 0.001 |  |  | |
IRS > 2 | 8/39 (20.5) | 27/40 (67.5) |  |  |